Mereo BioPharma (MREO) Exchange Rate Effect (2023 - 2026)
Mereo BioPharma's (MREO) quarterly Exchange Rate Effect came in at -$62000.0 in Q2 2026, down 104.34% year-over-year from $1.4 million in Q2 2025, and up 60.51% quarter-over-quarter from -$157000.0 in Q1 2026.
Powered by 
Analysis
Mereo BioPharma (MREO) Exchange Rate Effect (2023 - 2026) Analysis & Trends
Mereo BioPharma (MREO) has reported Exchange Rate Effect for 4 consecutive years, with -$62000.0 the latest figure, recorded in Q2 2026.
- On a quarterly basis, Exchange Rate Effect fell 104.34% year-over-year to -$62000.0 in Q2 2026; TTM through Jun 2026 was -$700000.0, a 130.72% decrease from a year earlier, with the FY2025 full-year figure at $1.9 million, up 895.71% from the prior year.
- Exchange Rate Effect was -$62000.0 for Q2 2026 at Mereo BioPharma, up from -$157000.0 in the prior quarter.
- Over five years, Exchange Rate Effect peaked at $1.7 million in Q4 2023 and troughed at -$1.3 million in Q4 2024.
- A 4-year average of $301428.6 and a median of -$62500.0 in 2025 frame the typical range for Exchange Rate Effect.
- Across the five-year window, Exchange Rate Effect slumped 174.91% in 2024 and soared 1433.64% in 2025, its largest moves.
- Over 4 years, Exchange Rate Effect stood at $1.7 million in 2023, then tumbled by 174.91% to -$1.3 million in 2024, then surged by 95.0% to -$63000.0 in 2025, then advanced by 1.59% to -$62000.0 in 2026.
- The last three Exchange Rate Effect figures came in at -$62000.0 (Q2 2026), -$157000.0 (Q1 2026), and -$63000.0 (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Exchange Rate Effect (Qtr) |
|---|---|---|---|---|---|
| 1 | Amgen | 206.44 Bn | 192.45 Bn | 7.24 Bn | - |
| 2 | Gilead Sciences | 179.97 Bn | 176.79 Bn | 6.22 Bn | -19.00 Mn |
| 3 | Vertex Pharmaceuticals | 130.57 Bn | 122.72 Bn | 2.84 Bn | -3.70 Mn |
| 4 | Regeneron Pharmaceuticals | 81.63 Bn | 73.63 Bn | 3.93 Bn | -300,000.00 |
| 5 | Argenx Se | 60.34 Bn | 55.16 Bn | 1.37 Bn | - |
| 6 | Moderna | 54.37 Bn | 49.23 Bn | 52.00 Mn | -2.00 Mn |
| 7 | Alnylam Pharmaceuticals | 33.07 Bn | 29.76 Bn | 992.69 Mn | -2.45 Mn |
| 8 | Biogen | 31.84 Bn | 30.55 Bn | 1.96 Bn | -3.40 Mn |
| 9 | Roivant Sciences | 29.49 Bn | 29.49 Bn | 1.16 Mn | 315,000.00 |
| 10 | Mereo BioPharma | 38.92 Mn | 38.92 Mn | - | -62,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -62,000.00 |
| Mar 31, 2026 | -157,000.00 |
| Dec 31, 2025 | -63,000.00 |
| Sep 30, 2025 | -418,000.00 |
| Jun 30, 2025 | 1.43 Mn |
| Mar 31, 2025 | 908,000.00 |
| Dec 31, 2024 | -1.26 Mn |
| Sep 30, 2024 | 1.20 Mn |
| Jun 30, 2024 | -107,000.00 |
| Mar 31, 2024 | -70,000.00 |
| Dec 31, 2023 | 1.68 Mn |
| Sep 30, 2023 | -1.00 Mn |
| Jun 30, 2023 | 846,000.00 |
| Mar 31, 2023 | 1.29 Mn |